CAPTRUST Financial Advisors
ECTE

CAPTRUST Financial Advisors’s ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) ECTE Stock Holding History

CAPTRUST Financial Advisors’s Portfolio ECTE Stock Details ECTE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-295
Closed – – 5357
2022
Q1 		$0 Buy
+295
New – ﹤0.01% 5349

CAPTRUST Financial Advisors's ECTE Position: Q2 2022 in Review

CAPTRUST Financial Advisors sold out of ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) (ECTE) in Q2 2022, closing a stake of 295 shares.

CAPTRUST Financial Advisors first reported a position in ECTE in Q1 2022 and held it in 1 quarter. The position peaked at $0 in Q1 2022. 0 funds tracked by Wall St. Rank hold ECTE as of Q2 2022.

  • CAPTRUST Financial Advisors reported no remaining ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) position as of Q2 2022 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 295 ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) shares in Q2 2022.
  • CAPTRUST Financial Advisors first reported a position in ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) in Q1 2022 and held it in 1 quarter.
  • CAPTRUST Financial Advisors's ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) position peaked at $0 in Q1 2022.
  • 0 funds tracked by Wall St. Rank held ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) as of Q2 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q2 2022, filed 16 Aug 2022.